Holders over time
- GH
- CI
| Quarter | GH | CI |
|---|---|---|
| Q3 2020 | 14 holders, $1.2bn | 34 holders, $18.1bn |
| Q4 2020 | 17 holders, $1.5bn | 22 holders, $21.9bn |
| Q1 2021 | 15 holders, $2.6bn | 24 holders, $23.9bn |
| Q2 2021 | 18 holders, $2.3bn | 31 holders, $22.5bn |
| Q3 2021 | 11 holders, $3.1bn | 30 holders, $17.8bn |
| Q4 2021 | 12 holders, $2.4bn | 26 holders, $20.1bn |
| Q1 2022 | 9 holders, $1.5bn | 28 holders, $20.4bn |
| Q2 2022 | 8 holders, $950m | 32 holders, $22.1bn |
| Q3 2022 | 9 holders, $1.3bn | 31 holders, $21.5bn |
| Q4 2022 | 11 holders, $731m | 30 holders, $24.7bn |
| Q1 2023 | 11 holders, $267m | 35 holders, $18.2bn |
| Q2 2023 | 14 holders, $752m | 30 holders, $19.8bn |
| Q3 2023 | 10 holders, $399m | 28 holders, $19.8bn |
| Q4 2023 | 9 holders, $433m | 31 holders, $20.6bn |
| Q1 2024 | 9 holders, $234m | 28 holders, $24.0bn |
| Q2 2024 | 9 holders, $323m | 28 holders, $19.5bn |
| Q3 2024 | 9 holders, $513m | 25 holders, $20.2bn |
| Q4 2024 | 11 holders, $599m | 23 holders, $15.2bn |
| Q1 2025 | 9 holders, $730m | 24 holders, $18.4bn |
| Q2 2025 | 10 holders, $843m | 34 holders, $19.5bn |
| Q3 2025 | 13 holders, $1.5bn | 28 holders, $16.2bn |
| Q4 2025 | 17 holders, $2.7bn | 21 holders, $14.6bn |
| Q1 2026 | 15 holders, $2.3bn | 26 holders, $13.5bn |
| Q2 2026 | 21 holders, $4.8bn | 28 holders, $13.0bn |
Guardant Health Inc
- Holders
- 17
- Reported value
- $2.7bn
- Buyers
- 23
- Sellers
- 13
Breadth +10 among 92 comparable managers.
The Cigna Group
- Holders
- 21
- Reported value
- $14.6bn
- Buyers
- 20
- Sellers
- 23
Breadth -3 among 92 comparable managers.
Who holds both, Q4 2025
Both (5)
Invesco Ltd, Man Group PLC, Quantbot Technologies LP, T. Rowe Price Associates Inc, Two Sigma Advisers LP
Only GH (12)
AllianceBernstein LP, ARK Investment Management LLC, Artisan Partners LP, Baillie Gifford & Co, Balyasny Asset Management LLC, Farallon Capital Management LLC, PDT Partners LLC, Point72 Asset Management LP, Polen Capital Management LLC, Renaissance Technologies LLC, Two Sigma Investments LP, Walleye Capital LLC
Only CI (16)
Acadian Asset Management LLC, AQR Capital Management LLC, Arrowstreet Capital LP, Bridgewater Associates LP, Capital Research Global Investors, Capital World Investors, Dodge & Cox, ExodusPoint Capital Management LP, Fidelity (FMR LLC), GAMCO Investors Inc, Glenview Capital Management LLC, Greenlight Capital, MFS Investment Management, Moore Capital Management LP, Neuberger Berman Group LLC, Squarepoint Ops LLC
How much of the picture this is
A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. Buyers and sellers count comparable managers (those that filed both quarters) by shares, so a rise in value with no rise in shares is the price. Large books are listed to their largest positions. These are 95 tracked managers, not the institutional market.